Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

Cancer Research

Volumn 65, Issue 11, 2005, Pages 4739-4746

  He, Yulong ^a   Rajantie, Iiro ^a   Pajusola, Katri ^a   Jeltsch, Michael ^a   Holopainen, Tanja ^a   Yla Herttuala, Seppo ^b   Harding, Thomas ^c   Jooss, Karin ^c   Takahashi, Takashi ^d   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c CELL GENESYS INC   (United States)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN RECEPTOR; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INVASION; CANCER STAGING; CELL INTERACTION; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; ENDOTHELIUM, LYMPHATIC; GENETIC VECTORS; HUMANS; IMMUNOGLOBULINS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MICE, SCID; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 21144437844     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-4576     Document Type: Article

References (34)

1. Stacker SA, Baldwin ME, Achen MG. The role of tumor lymphangiogenesis In metastatic spread. FASEB J 2002;16:922-34.
2. He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis, Biochim Biophys Acta 2004;1654:3-12.
3. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Metastasis: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-83.
4. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev 2002;16:773-83.
5. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice, Science 1997;276:1423-5.
6. Oh SJ, Jeltsch MM, Birkenhager R, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioal-lantoic membrane, Dev Biol 1997;188:96-109.
7. Velkkola T, Jussila L, Makinen T, et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001;20:1223-31.
8. Enholm B, Karpanen T, Jeltsch M, et al. Adenoviral expression of vascular endothelial growth factor-CInduces lymphangiogenesis in the skin, Circ Res 2001; 88:623-9.
9. Saaristo A, Veikkola T, Tammela T, et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 2002;196:719-30.
10. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001;7:186-91.
11. Makinen T. Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 2001;7:199-205.
12. Karkkainen MJ, Saaristo A, Jussila L, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 2001;98:12677-82.
13. Straume O, Jackson DG, Akslen LA. Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003;9:250-6.
14. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer, Cancer Res 2002;62:1315-20.
15. Rubbia-Brandt L, Terris B, Giostra E, Dousset B, Morel P, Pepper MS. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin Cancer Res 2004;10: 6919-28.
16. Sipos B, Klapper W, Kruse ML, Kalthoff H, Kerjaschki D, Kloppel G. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol 2004;65: 1187-97.
17. Skobe M, Hawighorst T. Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8.
18. Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001;61:1786-90.
19. He Y, Kozaki K, Karpanen T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling, J Natl Cancer Inst 2002;94:819-25.
20. Mattila MM, Ruohola JK, Karpanen T, Jackson DG. Alitalo K, Harkonen PL. VEGF-C induced lymphangio-genesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 2002;98:946-51.
21. Hawighorst T, Oura H, Streit M. et al. Thrombospondin-1 selectively inhibits early-stage cardnogenesis and anglogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 2002; 21:7945-56.
22. Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001;20:672-82.
23. He Y, Rajantie I, Ilmonen M, et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 2004;64: 3737-40.
24. Krishnan J, Kirkin V, Steffen A, et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D In tumors and its relationship to lymphatic metastasis In immunocompetent rats. Cancer Res 2003;63:713-22.
25. Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi I. Establishment and characterization of a human lung cancer cell line NCl-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 2000;60:2535-40.
26. Paterna JC. Moccetti T, Mura A, Feldon J, Bueler H. Influence of promoter and WHY post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther 2000;7: 1304-11.
27. Niwa H, Yamamura K, Miyazaki J, Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991;108:193-9.
28. Laitinen M, Makinen K, Manninen H, et al. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998;9:1481-6.
29. Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL. Apoptosis in torernifene-induced growth inhibition of human breast cancer cells in vivo and in vitro, J Natl Cancer Inst 1993;85:1412-8.
30. Karkkainen MJ, Haiko P, Sainio K, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 2004;5:74-80.
31. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium, J Biol Chem 2001;276:19420-30.
32. Sugino T, Kusakabe T, Hoshi N, et al. An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am J Pathol 2002;160: 1973-80.
33. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphanglogenesis in wound healing. Am J Pathol 2000;156:1499-304.
34. Mattfeldt T, Kestler HA, Sinn HP. Prediction of the axillary lymph node status in mammary cancer on the basis of clinicopathological data and flow cytometry. Med Biol Eng Comput 2004;42:733-9.